Lifevantage (LFVN) Misses Q1 EPS by 2c, provides guidance

Lifevantage (NASDAQ: LFVN) reported Q1 EPS of $0.14, $0.02 worse than the analyst estimate of $0.16. Revenue for the quarter came in at $47.2 million versus the consensus estimate of $49.63 million.

GUIDANCE:

Lifevantage sees FY2024 EPS of $0.70-$0.80, versus the consensus of $0.72. Lifevantage sees FY2024 revenue of $200-210 million, versus the consensus of $204.8 million.

For earnings history and earnings-related data on Lifevantage (LFVN) click here.

You May Also Be Interested In

• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• MacroGenics to receive $24.5M milestone from Sanofi on FDA approval
• Rocket Lab launches U.S. Space Force mission in record 16 hours